Generate Biomedicines Inc (GENB)

$12.17 -0.48 (-3.79%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,458,000
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A
JennyRowes
JennyRowes Mar. 14 at 3:26 PM
$GENB $ABSI $RXRX which AI drug dev leader do we think has more chops?? A) Najat Kahn B) Sean McCain C) Mike Nally
0 · Reply
tfinnerty
tfinnerty Mar. 12 at 4:29 PM
$GENB
0 · Reply
Sabertoothhawgtig
Sabertoothhawgtig Mar. 12 at 2:46 AM
$GENB quiet here……
0 · Reply
staydowngetdown
staydowngetdown Mar. 10 at 4:35 PM
$GENB 👀
1 · Reply
BoltTrade
BoltTrade Mar. 9 at 8:22 PM
Both $REBN and $GENB had good days with more profits being made AF. Tomorrow could be fun!
0 · Reply
b_dubs
b_dubs Mar. 6 at 10:06 PM
$GENB Nice; CEO buying at $12. I entered at 11.6ish today and was planning to add more lower on Monday but probably won't have the chance.
0 · Reply
quotient
quotient Mar. 6 at 9:19 PM
$GENB $MMED Now MMED too..
0 · Reply
quotient
quotient Mar. 6 at 6:46 PM
$GENB Whats behind the breakdown of the IPO and subsequent slide in price? GS and other underwriters are not doing anything to protect the price?
1 · Reply
BADBRAIN
BADBRAIN Mar. 5 at 6:13 PM
$GENB This will be $20 by the end of the month. Too many big players involved and an incredible pipeline that are already in late stages.
2 · Reply
blocktrade
blocktrade Mar. 5 at 1:52 PM
$GENB this will move once the initiations start coming in at the end of the month. Nvidia is an early investor
1 · Reply
Latest News on GENB
U.S. IPO Weekly Recap: Asthma-Focused Generate Biomedicines Closes Out February IPO Market

Feb 27, 2026, 9:25 PM EST - 15 days ago

U.S. IPO Weekly Recap: Asthma-Focused Generate Biomedicines Closes Out February IPO Market

Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut

Feb 27, 2026, 12:57 PM EST - 16 days ago

Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut

Drug developer Generate Biomedicines raises $400 million in US IPO

Feb 26, 2026, 8:11 PM EST - 16 days ago

Drug developer Generate Biomedicines raises $400 million in US IPO

Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

Feb 26, 2026, 7:58 PM EST - 16 days ago

Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering

Generate Biomedicines aims to raise $425 million in US IPO

Feb 23, 2026, 6:45 AM EST - 20 days ago

Generate Biomedicines aims to raise $425 million in US IPO

U.S. IPO Weekly Recap: IPO Market Stays Fairly Quiet During The Short Holiday Week

Feb 20, 2026, 9:40 PM EST - 22 days ago

U.S. IPO Weekly Recap: IPO Market Stays Fairly Quiet During The Short Holiday Week

GRAY MMED MTVE ROC

U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years

Feb 6, 2026, 10:00 PM EST - 5 weeks ago

U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years

AGBK AGMB OXY ARKO BOBS CEPS EIKN

Generate Biomedicines Begins IPO Push With Major Collaboration Deals

Feb 6, 2026, 1:16 PM EST - 5 weeks ago

Generate Biomedicines Begins IPO Push With Major Collaboration Deals

Generate Biomedicines, Clinical-Stage Generative Biology Company Designing AI-Engineered Protein Therapeutics, Files for Nasdaq IPO

Feb 4, 2026, 5:08 PM EST - 5 weeks ago

Generate Biomedicines, Clinical-Stage Generative Biology Company Designing AI-Engineered Protein Therapeutics, Files for Nasdaq IPO

Generate Biomedicines IPO Registration Document (S-1)

Feb 4, 2026, 5:02 PM EST - 5 weeks ago

Generate Biomedicines IPO Registration Document (S-1)

Asthma-focused AI biotech Generate Biomedicines files for a $100 million US IPO

Feb 4, 2026, 7:28 AM EST - 5 weeks ago

Asthma-focused AI biotech Generate Biomedicines files for a $100 million US IPO

JennyRowes
JennyRowes Mar. 14 at 3:26 PM
$GENB $ABSI $RXRX which AI drug dev leader do we think has more chops?? A) Najat Kahn B) Sean McCain C) Mike Nally
0 · Reply
tfinnerty
tfinnerty Mar. 12 at 4:29 PM
$GENB
0 · Reply
Sabertoothhawgtig
Sabertoothhawgtig Mar. 12 at 2:46 AM
$GENB quiet here……
0 · Reply
staydowngetdown
staydowngetdown Mar. 10 at 4:35 PM
$GENB 👀
1 · Reply
BoltTrade
BoltTrade Mar. 9 at 8:22 PM
Both $REBN and $GENB had good days with more profits being made AF. Tomorrow could be fun!
0 · Reply
b_dubs
b_dubs Mar. 6 at 10:06 PM
$GENB Nice; CEO buying at $12. I entered at 11.6ish today and was planning to add more lower on Monday but probably won't have the chance.
0 · Reply
quotient
quotient Mar. 6 at 9:19 PM
$GENB $MMED Now MMED too..
0 · Reply
quotient
quotient Mar. 6 at 6:46 PM
$GENB Whats behind the breakdown of the IPO and subsequent slide in price? GS and other underwriters are not doing anything to protect the price?
1 · Reply
BADBRAIN
BADBRAIN Mar. 5 at 6:13 PM
$GENB This will be $20 by the end of the month. Too many big players involved and an incredible pipeline that are already in late stages.
2 · Reply
blocktrade
blocktrade Mar. 5 at 1:52 PM
$GENB this will move once the initiations start coming in at the end of the month. Nvidia is an early investor
1 · Reply
nottoday800
nottoday800 Mar. 4 at 8:33 PM
$GENB how is someone buying at 16 when the high is 13?
1 · Reply
prodigy81
prodigy81 Mar. 4 at 5:45 PM
$GENB I learned this one today. What is this guy doing?
0 · Reply
b_dubs
b_dubs Mar. 3 at 6:49 PM
$GENB Insiders buying at Ip price of 16, but at 11.30 rn. Ouch. Not a market endorsement
1 · Reply
BADBRAIN
BADBRAIN Mar. 3 at 4:53 PM
$GENB They have two in the pipeline already in Phase 3 and big money behind them. It won't be a long wait til this goes ballistic.
0 · Reply
Tony_37
Tony_37 Mar. 2 at 11:10 PM
$GENB 🚀🎁💎
0 · Reply
theflynews
theflynews Mar. 2 at 4:37 PM
Opening Day: Generate Biomedicines makes public debut - $GENB - https://legacy.thefly.com/permalinks/entry.php/id4304845
0 · Reply
JennyRowes
JennyRowes Mar. 2 at 3:46 PM
$GENB platform sounds like a direct challenge to $ABSI
0 · Reply
TigerEyeCF
TigerEyeCF Mar. 2 at 2:35 PM
$GENB I’ll consider accumulation at $9. Series B/C I believe are in at $18.
0 · Reply
JennyRowes
JennyRowes Mar. 1 at 6:58 PM
$APGE competing program from $GENB
0 · Reply
JennyRowes
JennyRowes Mar. 1 at 6:52 PM
$GENB watching this one alongside $RXRX, $ABSI and $ABCL
0 · Reply
GrandAdmiralThrawn
GrandAdmiralThrawn Feb. 28 at 10:23 PM
$GENB this has some decent backers has to be for a reason.
0 · Reply
RDCCAPITOl1
RDCCAPITOl1 Feb. 28 at 4:58 PM
$GENB Started a small long position at $11.67, will see how it goes
2 · Reply